JALYN - 0173-0809-59 - (dutasteride and tamsulosin hydrochloride)

Alphabetical Index


Drug Information of JALYN

Product NDC: 0173-0809
Proprietary Name: JALYN
Non Proprietary Name: dutasteride and tamsulosin hydrochloride
Active Ingredient(s): .5; .4    mg/1; mg/1 & nbsp;   dutasteride and tamsulosin hydrochloride
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of JALYN

Product NDC: 0173-0809
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022460
Marketing Category: NDA
Start Marketing Date: 20100621

Package Information of JALYN

Package NDC: 0173-0809-59
Package Description: 90 CAPSULE in 1 BOTTLE (0173-0809-59)

NDC Information of JALYN

NDC Code 0173-0809-59
Proprietary Name JALYN
Package Description 90 CAPSULE in 1 BOTTLE (0173-0809-59)
Product NDC 0173-0809
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name dutasteride and tamsulosin hydrochloride
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20100621
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name DUTASTERIDE; TAMSULOSIN HYDROCHLORIDE
Strength Number .5; .4
Strength Unit mg/1; mg/1
Pharmaceutical Classes 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA],Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]

Complete Information of JALYN


General Information